My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
Array ( [direction] => 1 [market_status] => green )
Jubilant Life Sciences today said it has received the US health regulator's approval for the launch of Pantoprazole Delayed Release Tablets 20 mg and 40mg.
You are already a Moneycontrol Pro user.